Adenosine triphosphate release and purinergic (P2) receptor–mediated secretion in small and large mouse cholangiocytes†
Article first published online: 29 OCT 2010
Copyright © 2010 American Association for the Study of Liver Diseases
Volume 52, Issue 5, pages 1819–1828, November 2010
How to Cite
Woo, K., Sathe, M., Kresge, C., Esser, V., Ueno, Y., Venter, J., Glaser, S. S., Alpini, G. and Feranchak, A. P. (2010), Adenosine triphosphate release and purinergic (P2) receptor–mediated secretion in small and large mouse cholangiocytes. Hepatology, 52: 1819–1828. doi: 10.1002/hep.23883
Potential conflict of interest: Nothing to report.
- Issue published online: 29 OCT 2010
- Article first published online: 29 OCT 2010
- Manuscript Accepted: 22 JUL 2010
- Manuscript Received: 21 SEP 2009
- Cystic Fibrosis Foundation (FERANC08G0)
- Children's Medical Center Foundation
- National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health. Grant Numbers: DK078587, DK054811
- VA Merit Award
Adenosine triphosphate (ATP) is released from cholangiocytes into bile and is a potent secretogogue by increasing intracellular Ca2+ and stimulating fluid and electrolyte secretion via binding purinergic (P2) receptors on the apical membrane. Although morphological differences exist between small and large cholangiocytes (lining small and large bile ducts, respectively), the role of P2 signaling has not been previously evaluated along the intrahepatic biliary epithelium. The aim of these studies therefore was to characterize ATP release and P2-signaling pathways in small (MSC) and large (MLC) mouse cholangiocytes. The findings reveal that both MSCs and MLCs express P2 receptors, including P2X4 and P2Y2. Exposure to extracellular nucleotides (ATP, uridine triphosphate, or 2′,3′-O-[4-benzoyl-benzoyl]-ATP) caused a rapid increase in intracellular Ca2+ concentration and in transepithelial secretion (Isc) in both cell types, which was inhibited by the Cl− channel blockers 5-nitro-2-(-3-phenylpropylamino)-benzoic acid (NPPB) or niflumic acid. In response to mechanical stimulation (flow/shear or cell swelling secondary to hypotonic exposure), both MSCs and MLCs exhibited a significant increase in the rate of exocytosis, which was paralleled by an increase in ATP release. Mechanosensitive ATP release was two-fold greater in MSCs compared to MLCs. ATP release was significantly inhibited by disruption of vesicular trafficking by monensin in both cell types. Conclusion: These findings suggest the existence of a P2 signaling axis along intrahepatic biliary ducts with the “upstream” MSCs releasing ATP, which can serve as a paracrine signaling molecule to “downstream” MLCs stimulating Ca2+-dependent secretion. Additionally, in MSCs, which do not express the cystic fibrosis transmembrane conductance regulator, Ca2+-activated Cl− efflux in response to extracellular nucleotides represents the first secretory pathway clearly identified in these cholangiocytes derived from the small intrahepatic ducts. (HEPATOLOGY 2010)
Cholangiocytes, the epithelial cells that form the intrahepatic bile ducts, represent an important component of the bile secretory unit. Although bile formation is initiated at the hepatocyte canalicular membrane, cholangiocytes subsequently modify the composition of bile through regulated ion secretion throughout the network of bile ducts.1 Interestingly, secretory mechanisms along the intrahepatic bile ducts are not uniform. In all biliary models studied, including human, rat, and mouse bile ducts, cholangiocytes are known to be morphologically and functionally heterogeneous. Large cholangiocytes, from large ducts, express secretin receptors on the basolateral membrane and express cystic fibrosis transmembrane conductance regulator (CFTR) and the HCO3−/Cl− anion exchanger 2 (AE2) on the apical membrane,2-4 and hence respond to secretin with an increase in [cAMP] (intracellular cyclic adenosine monophosphate concentration), and subsequent Cl− and HCO3− efflux into the lumen. Conversely, small cholangiocytes, from small ducts, do not express secretin receptors, CFTR, or HCO3−/Cl− exchanger and do not exhibit a secretory response to secretin.3 In human liver, parallel to the findings observed in the rat and mouse, secretin-stimulated duct secretory activity is heterogeneous, because only medium and large interlobular bile ducts express the Cl−/HCO3− exchanger AE2.5
Recently, secretion mediated by extracellular nucleotides (e.g., adenosine triphosphate [ATP]) acting on purinergic (P2) receptors on the luminal membrane of biliary epithelial cells has emerged as functionally important. ATP is present in bile,6 and binding of ATP to P2 receptors increases K+7,8 and Cl− efflux from isolated cholangiocytes9, 10 and dramatically increases transepithelial secretion in biliary epithelial monolayers.10, 11 Indeed, the magnitude of the secretory response to ATP is two-fold to three-fold greater than that to cAMP.10 Interestingly, recent evidence suggests that even cAMP-stimulated bile flow is mediated by ATP release into the duct lumen and stimulation of apical P2 receptors.12 Together, these studies challenge and extend the conventional model that centers on the concept that cAMP-dependent opening of CFTR-related Cl− channels is the driving force for cholangiocyte secretion. Rather, the operative regulatory pathways appear to take place within the lumen of intrahepatic ducts, where release of ATP into bile is a final common pathway controlling ductular bile formation. In light of recent studies demonstrating that the mechanical effects of fluid-flow or shear stress at the apical membrane of biliary epithelial cells is a robust stimulus for ATP release,13 a model emerges in which mechanosensitive ATP release and Cl− secretion is a dominant pathway regulating biliary secretion.
Although cholangiocytes express a repertoire of both P2X and P2Y receptors,11, 14, 15 it is unknown if expression differs between small and large cholangiocytes and/or if functional differences exist in ATP release and signaling along the bile duct. The aim of the current studies therefore was to determine if a potential P2 signaling axis may exist along the bile duct by evaluating mechanosensitive ATP release and exocytosis, P2 receptor expression and function, and secretion mediated by extracellular nucleotides in both small (MSC) and large (MLC) mouse cholangiocytes.
Materials and Methods
Studies were performed in mouse cholangiocytes isolated from normal mice (BALB/c) and immortalized by transfection with the simian virus 40 large-T antigen gene.4 These cells demonstrate identical properties to freshly isolated small and large mouse cholangiocytes.3 Cells were maintained in culture as described.3, 4 Additional studies of P2 receptor expression were performed in primary cholangiocytes isolated from C57BL/6 mice (Charles River, Wilmington, MA) as previously described.16, 17 All animal experiments were performed in accordance with a protocol approved by the Scott & White Institutional Animal Care and Use Committee and in accordance with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Total RNA Isolation and RT-PCR Analysis.
Total RNA was extracted using TRIZOL Reagent (Invitrogen, Carlsbad, CA) and 1 μg RNA was reverse transcribed in the presence of 100 pmol oligo-deoxythymidine primer. For reverse transcription polymerase chain reaction (RT-PCR), aliquots of 5% of the total complementary DNA were amplified with TaqDNA polymerase in a reaction mixture containing 20 pmol of 5′ and 3′ primers specifically designed for various P2X and P2Y receptors (Supporting Information Methods and Supporting Information Table 1).
Measurement of Intracellular Ca2+ Concentration.
MLCs and MSCs were grown to confluence on coverglass (Fig. 2), loaded with 2.5 μg/mL of fura-2-acetoxymethyl ester (fura-2-AM; TEF Laboratories, Austin, TX), placed in a perfusion chamber (RC-25F/PHA; Warner Instruments) on the stage of an inverted fluorescence microscope (Nikon TE2000), and the inflow and outflow ports were connected to a syringe pump. Changes of [Ca2+]i (the intracellular calcium concentration) were measured at excitation wavelength of 340 nm (calcium-bound fura-2-AM) and 380 nm (calcium-free fura-2-AM), and emission wavelength of 510 nm and [Ca2+]i was calculated.
Confluent MSCs and MLCs were incubated with acetylated α-tubulin antibody (Sigma), as a marker for the primary cilium, and rhodamine phalloidin (Invitrogen) to label actin. Imaging was performed using a PerkinElmer UltraVIEW ERS spinning disk confocal microscope (PerkinElmer, Boston, MA). Imaris 5.0 (Bitplane, Inc., Saint Paul, MN) was used for three-dimensional volume rendering of z-stacks.
Measurement of Exocytosis.
Exocytosis was assessed by real time imaging using the fluorescent dye FM1-43 (Molecular Probes, Inc., Eugene, OR) as previously described.18 FM1-43 is weakly fluorescent in aqueous solution, but its fluorescence increases >300-fold when it binds plasma membrane and, therefore, it is a useful dye for the measurement of increased plasma membrane due to fusion of vesicle membrane with the plasma membrane during exocytosis.
Measurement of ATP Release.
Bulk ATP release was studied from confluent cells using the luciferin-luciferase (L-L) assay as previously described.13, 19, 20 Cell swelling was induced by adding water to dilute media 33% and defined shear stress was applied to confluent cells in a parallel plate chamber. All luminescence values are reported as relative change from basal luminescence per total protein level in the sample (measured in micrograms per milliliter) to control for any potential differences in luciferase activity or confluency between samples, respectively. Detailed protocols for measurements of ATP release, ATP degradation, protein levels, and lactate dehydrogenase are described in Supporting Information Methods.
Transepithelial Cl− Secretion.
MLCs and MSCs were grown on collagen-coated polycarbonate filters with a pore size of 0.4 μm (Costar, Cambridge, MA) and the transmembrane resistance was measured daily (Evohm voltmeter; World Precision Instruments, Sarasota, FL).21 Filters were mounted in an Ussing chamber, filled with standard buffer solution, and transepithelial short-circuit current response (Isc) was measured under 0 mV voltage-clamp conditions through agar bridges connected to Ag-AgCl electrodes using an epithelial voltage clamp amplifier (model EC-825; Warner Instruments, MRA International, Naples, FL). The Isc represents the net sum of the transepithelial fluxes of anion and cation and the level of ion secretion.11 Studies included paired, same-day monolayers to minimize any potential effects of day-to-day variability.
Reagents and Statistics.
Detailed descriptions of the reagents, buffer solutions, experimental protocols, and statistical analysis are provided in Supporting Information Materials.
Large and Small Cholangiocytes Express a Repertoire of P2X and P2Y Receptors.
In both MLCs and MSCs, complementary DNAs were probed with oligonucleotide primers specific to the seven P2X subtypes and seven P2Y subtypes in mouse (shown in Supporting Information Table 1) and amplified using RT-PCR. Representative studies are shown in MLCs and MSCs (Fig. 1), and in primary isolated cholangiocytes (Supporting Information Fig. 1). In both MLCs and MSCs, clear bands corresponding to P2X4 and all seven P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, and P2Y13) are present. These results are consistent with previous studies of human and rat biliary cells where a predominance of P2X4 and multiple P2Y receptors were observed.11, 14, 15
Agonist Profile of Nucleotide-Stimulated Ca2+ Fluorescence.
To establish the functional significance of mouse cholangiocyte P2 receptor expression, MSCs and MLCs were grown to confluence (Fig. 2) and changes in Ca2+ fluorescence measured in response to P2Y and P2X agonists. Exposure to ATP, UTP, a P2Y-preferring agonist, or Bz-ATP, a P2X-preferring agonist, all resulted in significant increases in [Ca2+]i in both MLCs and MSCs (Fig. 3). The ATP-stimulated increase in [Ca2+]i was abolished by the P2Y receptor blocker, suramin (Fig. 3D). Together, these results demonstrate that P2X4 and P2Y receptors expressed by both MLCs and MSCs are functionally active. No differences were observed between MLCs and MSCs in either the magnitude or kinetics of the Ca2+ response to any of the nucleotides.
Functional Role for P2 Receptors in Transepithelial Secretion.
When cultured as described, both MSCs and MLCs developed an increase in transmembrane resistance by day 3 signifying the development of confluent monolayers with tight junctions (Fig. 4A). When mounted in an Ussing chamber, confluent MLCs and MSCs monolayers exhibited a basal Isc, reflecting transepithelial secretion, which increased dramatically in response to the addition of ATP (100 μM) to the apical chamber (Fig. 4B,C). The nucleotide-stimulated Isc was significantly inhibited by the nonspecific Cl− channel blocker, 5-nitro-2-(-3-phenylpropylamino)-benzoic acid (NPPB), or by the Ca2+-activated Cl− channel blocker niflumic acid (Fig. 4C,F). Additionally, preincubation with the IP3 receptor blocker, 2-APB, significantly inhibited the ATP-stimulated increase in Iscin both MLC and MSC (Fig. 4C). In separate experiments, the effect of apical versus basolateral P2 receptor stimulation on the Isc was determined. For both MSCs and MLCs, an increase in the Isc was observed when nucleotides were added to either chamber, consistent with functional expression of P2 receptors on both apical and basolateral membranes. The magnitude of the change in Isc was similar when nucleotides were added to either apical or basolateral compartments for all nucleotides tested except for UTP which caused a significantly greater increase in Isc when added apically versus basolateral addition. Thus, both MSCs and MLCs express functional P2 receptors on both apical and basolateral membranes. Nucleotide binding to P2 receptors causes an increase in [Ca2+]i, predominantly through an IP3 receptor-dependent mechanism, which stimulates Ca2+-activated Cl− channels, and results in transepithelial secretion. To our knowledge, these represent the first integrated Isc measurements of transepithelial secretion in mouse cholangiocytes. Furthermore, in MSC, which do not express CFTR, Ca2+-activated Cl− efflux in response to extracellular nucleotides represents the first secretory pathway clearly identified in these cells derived from the small intrahepatic ducts.
Mechanosensitive ATP Release.
In human biliary cells and normal rat cholangiocyte monolayers, mechanical stimulation,22 shear stress,13 and cell swelling secondary to hypotonic exposure,22 have all been identified as significant stimuli for ATP release. Studies were performed to determine if these mechanical stimuli result in a similar increase in the magnitude of ATP release in mouse cholangiocytes. First, in response to hypotonic exposure (33% dilution) to stimulate cell swelling, a rapid and large increase in ATP release was observed in both MLCs and MSCs (Fig. 5A). The magnitude of the response, which peaked within 30 seconds, was significantly greater in MSCs versus MLCs (Fig. 5A,C). Separate studies were performed to assess the effects of shear on ATP release. Under low shear conditions (shear 0.08 dyne/cm2) no increase in ATP release was observed; however, increasing shear to 0.64 dyne/cm2 caused a rapid relative increase in ATP release in both MLCs and MSCs, and again the magnitude of the peak response was significantly greater in MSCs versus MLCs (P < 0.05, Fig. 5B,C). No difference was noted in lactate dehydrogenase measurements before or after stimulus, for either hypotonic or shear exposure, excluding cell lysis as contributing to measured ATP (data not shown). In other biliary models, ATP release has been linked to exocytosis.18 To determine if exocytosis contributes to ATP release in MLCs and MSCs, studies were performed in the presence or absence of monensin, a carboxylic ionophore known to dissipate the transmembrane pH gradients in Golgi and lysosomal compartments and disrupt vesicular trafficking. In both MLCs and MSCs, monensin significantly inhibited swelling-induced (33% hypotonic exposure) ATP release (Fig. 5D). Thus, both MSCs and MLCs exhibit mechanosensitive ATP release which is dependent on intact vesicular trafficking pathways. Additionally, the magnitude of mechanosensitive ATP release is significantly greater (∼two-fold) in MSCs compared to MLCs.
To determine if the difference in ATP release observed between MSCs and MLCs are the result of generalized differences in total cellular exocytosis, rates of exocytosis were measured in response to mechanical stimuli in both cell types. After equilibration with FM1-43, cells were exposed to hypotonic buffer (33%) which was associated with a rapid increase in fluorescence, reflecting an increase in exocytosis (Fig. 6). In separate studies, exposure to shear (0.64 dyne/cm2) also resulted in an increase in exocytosis (Fig. 6). These findings suggest a functional link between exocytosis and ATP release in both MLCs and MSCs. There was no significant difference noted in the rate or magnitude of exocytosis between MLCs and MSCs in response to either of these mechanical stimuli.
The concentration of extracellular ATP in bile is regulated not only through the rate of ATP release, but also through degradation pathways.23 To determine if differences exist in the kinetics of ATP degradation between MSCs and MLCs, the media bathing confluent cells was loaded with exogenous ATP (10 nM). Changes in bioluminescence were monitored continuously until relative ALU returned to basal levels. As shown in Fig. 7, addition of ATP (10 nM) to MLCs increased relative bioluminescence 2.7-fold. The time course of degradation was described by a single exponential (y = ae−0.038 min, r = 0.99). By comparison, addition of ATP to MSCs increased bioluminescence 2.5-fold with a similar rate of degradation described by a single exponential (y = ae−0034min, r = 0.99). Thus, MLCs and MSCs display functionally similar ATP degradation pathways.
The present studies extend the observations regarding the specialized function of cholangiocytes by identifying and characterizing the elements of the purinergic signaling axis in cholangiocytes derived from distinct functional areas along the intrahepatic bile ducts. Using molecular, pharmacological, and functional biophysical approaches the principal findings in these studies of mouse cholangiocytes are: (1) both small and large cholangiocytes express a repertoire of both P2X and P2Y receptors; (2) both small and large cholangiocytes develop polarized epithelial monolayers with a high transepithelial resistance and demonstrate rapid increases in [Ca2+]i and transepithelial secretion (Isc) upon exposure to extracellular nucleotides; (3) nucleotide-stimulated secretion is dependent on IP3 receptor-mediated increases in [Ca2+]i and Ca2+-activated Cl− channel activation; (4) both small and large cholangiocytes demonstrate mechanosensitive ATP release which is dependent on intact vesicular trafficking pathways; and (5) the magnitude of mechanosensitive ATP release is significantly greater in small versus large cholangiocytes. Thus, these studies demonstrate that both small and large cholangiocytes express all components of the purinergic signaling axis and collectively, provide a working model for mechanosensitive ATP-stimulated secretion along intrahepatic bile ducts. Additionally, the ATP-mediated secretory pathway identified in the mouse small cholangiocytes, which do not exhibit secretin-stimulated secretion,3, 17 represent the first identification of a secretory pathway in these specialized cells. The existence of a gradient along the biliary axis, wherein ATP released from small cholangiocytes “upstream” may represent an important paracrine signal to the “downstream” P2 receptor-expressing large cholangiocytes, has important implications for bile formation (Fig. 8).
Although regulated ATP release has been identified in all liver cells studied, including both human and rat hepatic parenchymal cells and biliary epithelial cells,20, 22 these are the first studies to characterize ATP release in mouse cholangiocytes, and several observations deserve highlighting. First, the magnitude of ATP release from small cholangiocytes was significantly greater than that from large cholangiocytes. Because the mechanism of cholangiocyte ATP release has not been identified, the cellular basis for this difference in ATP release cannot be determined. Although CFTR has been proposed as a regulator of ATP release,12, 24, 25 MSC do not express CFTR,17 suggesting alternate ATP release pathways in these cells. One proposed alternate mechanism involves exocytosis of ATP-enriched vesicles. In fact, biliary cells possess a dense population of vesicles ∼140 nm in diameter in the subapical space,26 and increases in cell volume increase the rate of exocytosis to values sufficient to replace ∼30% of plasma membrane surface area within minutes. In the current studies, stimuli associated with ATP release were also associated with parallel increases in the rate of exocytosis, and disruption of vesicular trafficking significantly decreased ATP release. Notably, overall rates of exocytosis in response to mechanosensitive stimuli did not vary significantly between MLCs and MSCs, despite a significantly greater release of ATP from MSCs, given the same stimulus. This may suggest the existence of distinct vesicle populations contributing to regulated ATP release. In fact, recent findings in rat liver cells suggest that a distinct population of ATP-enriched vesicles may contribute to regulated ATP release.27 In some cell types, the concentration of ATP within secretory vesicles may approach 50 mM28 and, therefore, only several vesicles per cell may account for substantial differences in the concentration of ATP released into the extracellular space. Differences observed in the magnitude of ATP release between MSCs and MLCs may be related to variation in the regulation and/or trafficking of specific vesicles involved in ATP transport (either ATP-containing vesicles and/or vesicles transporting an ATP transporter to the membrane). This regulation may occur at the level of vesicle “priming”, trafficking, or membrane fusion/release, though clearly further work is required. Nonetheless, if these observations apply to in vivo conditions, greater ATP release from small cholangiocytes would translate into a significant increase in the concentration of ATP in bile in the “upstream” intrahepatic ducts, given their smaller cross-sectional area and relative volume.29
Second, it is notable that extracellular nucleotides elicit secretory responses when applied at both apical and basolateral membranes. The apical membrane specifically represents an anatomic orientation that is well suited for hepatocyte-to-cholangiocyte or cholangiocyte-to-cholangiocyte signaling by release of ATP into bile. This is notably distinct from secretin and other hormones that are delivered to the basolateral membrane through the bloodstream.1 ATP release from the hepatocyte canalicular membrane may signal to downstream small and large cholangiocytes through apical P2 receptor stimulation in a process known as hepatobiliary coupling. Hepatobiliary coupling has also been described for bile acids, which are released from the hepatocyte canalicular membrane and may be transported into “downstream” cholangiocytes via the apical Na+-dependent bile acid transporter located on large, but not small, cholangiocytes.30 Interestingly, Ursodeoxycholic acid is associated with cholangiocyte ATP release and Cl− secretion.24 Thus, the ductal concentration of ATP appears to be an important determinant of bile formation and may represent a final common pathway in coupling hepatocyte transport to cholangiocyte secretion.
Lastly, the relative importance of secretin- versus P2 receptor-mediated secretion, in bile formation is unknown. The molecular identity of the Cl− channel(s) activated in response to ATP remains undefined in biliary epithelium, though it appears to be unrelated to CFTR.10 Furthermore, although we have previously identified the Ca2+-activated K+ channels, SK2 and IK-1, in rat and human biliary epithelial cells,7, 8 the expression and contribution of these channels to secretion in mouse cholangiocytes has not been defined.
In conclusion, the present studies represent a functional characterization of the purinergic signaling axis in mouse cholangiocytes from distinct areas of the intrahepatic biliary tree. The findings support a model wherein ATP released from small cholangiocytes lining the “upstream” small intrahepatic bile ducts may contribute importantly to local purinergic signaling, serve as a source for ATP in bile, and represent an important paracrine signal to the large cholangiocytes lining the larger “downstream” bile ducts. Targeting P2 receptor-mediated signaling pathways in intrahepatic biliary epithelial cells may provide new and innovative strategies for stimulating bile formation in the treatment of cholestatic liver diseases.
- 1Cellular mechanisms of bile secretion. In: ZakimD, BoyerTD, eds. Hepatology. ed 3. Philadelphia: W.B. Saunders Co.; 1996: 362-376.
- 29Three-dimensional reconstruction of the rat intrahepatic biliary tree: physiologic implications. In: AlpiniG, AlvaroD, MarzioniM, LesageG, LaRussoN, eds. The Pathophysiology of Biliary Epithelia. Georgetown, TX: Landes Bioscience; 2004: 60-71., , ,
Additional Supporting Information may be found in the online version of this article.
|HEP_23883_sm_SuppFig1.tif||1159K||Supporting Information Figure 1.|
|HEP_23883_sm_SuppFig2.tif||6273K||Supporting Information Figure 2.|
|HEP_23883_sm_SuppTable1.doc||37K||Supporting Information Table 1.|
|HEP_23883_sm_SuppMaterials.doc||91K||Supporting Information Materials.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.